Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hydrocodone bitartrate + acetaminophen (Sun Pharma)
- Development stage
- Phase 1
- Lead developer
- SPARC
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Hydrocodone bitartrate and acetaminophen is a combination small molecule analgesic developed by Sun Pharma Advanced Research Company Limited (SPARC) for the management of moderate-to-severe pain. This specific formulation is designed with potential abuse-deterrent properties. Hydrocodone bitartrate acts as a semi-synthetic opioid agonist that primarily targets mu-opioid receptors in the central nervous system to provide potent analgesia. Acetaminophen serves as a non-opioid analgesic and antipyretic, likely acting through the inhibition of cyclooxygenase (COX) enzymes and subsequent prostaglandin synthesis in the CNS. The product has been evaluated in clinical trials, such as NCT03567941, to assess its relative abuse potential compared to established branded products like Norco in non-dependent, recreational opioid users under various conditions.
- Other names
- Hydrocodone/AcetaminophenHydrocodone/APAP
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)
Beyond the preview
Go deeper on hydrocodone bitartrate + acetaminophen (Sun Pharma).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hydrocodone bitartrate + acetaminophen (Sun Pharma).